Cargando…

Modeling the Progression of Cardiac Catecholamine Deficiency in Lewy Body Diseases

BACKGROUND: Lewy body diseases (LBDs) feature deficiency of the sympathetic neurotransmitter norepinephrine in the left ventricular myocardium and sympathetic intra‐neuronal deposition of the protein alpha‐synuclein (αS). LBDs therefore are autonomic synucleinopathies. Computational modeling has rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldstein, David S., Pekker, Mark J., Sullivan, Patti, Isonaka, Risa, Sharabi, Yehonatan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238705/ https://www.ncbi.nlm.nih.gov/pubmed/35621196 http://dx.doi.org/10.1161/JAHA.121.024411

Ejemplares similares

Cardiac sympathetic innervation and vesicular storage in pure autonomic failure
por: Goldstein, David S., et al.
Publicado: (2020)

The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease
por: Landau, Regev, et al.
Publicado: (2022)

Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson’s disease: a post-mortem observational study
por: Isonaka, Risa, et al.
Publicado: (2022)

Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies
por: Lamotte, Guillaume, et al.
Publicado: (2020)

Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure
por: Lenka, Abhishek, et al.
Publicado: (2023)

Plasma Catechols After Eating Olives
por: Goldstein, David S., et al.
Publicado: (2017)

Lewy body disease or diseases with Lewy bodies?
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Jellinger, Kurt A.
Publicado: (2022)

Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body disease
por: Serrano, Geidy E, et al.
Publicado: (2020)

Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases
por: Tanei, Zen-ichi, et al.
Publicado: (2020)

Effects of Mind-Body Training on Cytokines and Their Interactions with Catecholamines
por: Jang, Joon Hwan, et al.
Publicado: (2017)

Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease
por: Hamilton, Calum A., et al.
Publicado: (2021)

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
por: Su, Bo, et al.
Publicado: (2009)

Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease
por: Khashab, Rawan, et al.
Publicado: (2023)

Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression
por: van de Beek, Marleen, et al.
Publicado: (2020)

Progressive fuzzy cation-π assembly of biological catecholamines
por: Hong, Seonki, et al.
Publicado: (2018)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Lewy body constipation
por: Sakakibara, Ryuji, et al.
Publicado: (2019)

Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database
por: Chandler, Julie, et al.
Publicado: (2022)

Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies
por: Roberts, Gemma, et al.
Publicado: (2021)

Progressive Bálint's Syndrome in a Patient Demonstrating Dementia with Lewy Bodies
por: Sakurai, Yasuhisa, et al.
Publicado: (2017)

Molecular Pathology of Lewy Body Diseases
por: Beyer, Katrin, et al.
Publicado: (2009)

Parkin Disease and the Lewy Body Conundrum
por: Doherty, Karen M, et al.
Publicado: (2013)

Clinical biomarkers for Lewy body diseases
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
por: Galvin, James E.
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases
por: Odagiri, Hayato, et al.
Publicado: (2016)

High-Fructose Diet Increases Renal ChREBPβ Expression, Leading to Intrarenal Fat Accumulation in a Rat Model with Metabolic Syndrome
por: Bier, Ariel, et al.
Publicado: (2022)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Striatal oxidative damages and neuroinflammation correlate with progression and survival of Lewy body and Alzheimer diseases
por: Li, Huifangjie, et al.
Publicado: (2021)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

Fabry Disease With Concomitant Lewy Body Disease
por: Del Tredici, Kelly, et al.
Publicado: (2020)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
por: Hatton, Christopher, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_251icd816vt04knvj60uk7de1f